Serum DCAMKL1 Pre and Post Treatment in Patients With Pancreatic Cancer
Serum DCAMKL1 Pre and Post Treatment in Patients With Pancreatic Cancer
Active, not recruiting · NCT01580241 · Registry updated 2026-04-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Serum DCAMKL1 Pre and Post Treatment in Patients With Pancreatic Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Active, not recruiting | Not stated | 2026-04-01 | NCT01580241 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Oklahoma | 146 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Stephensen Cancer Center | Oklahoma City | United States | 1 |